Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein kinases are crucial enzymes regulating cellular processes like cell cycle and metabolism.
• Dysregulation of protein kinases, through mechanisms like overexpression or mutations, is implicated in various diseases, particularly cancer.
• The human genome encodes approximately 538 kinases, highlighting their widespread importance.

Purpose of the Study:

• To review FDA-approved kinase inhibitors.
• To discuss their mechanisms of action, clinical benefits, and associated side effects.
• To explore challenges in managing side effects and future prospects for novel kinase inhibitor development.

Main Methods:

• Literature review of FDA-approved kinase inhibitors.
• Analysis of mechanisms, clinical efficacy, and adverse events.
• Discussion of therapeutic challenges and future research directions.

Main Results:

• Kinase inhibitors have shown significant clinical benefits in treating various cancers.
• Understanding kinase function has enabled targeted therapeutic strategies.
• Side effects associated with kinase inhibitors present challenges that require management.

Conclusions:

• Kinase inhibitors represent a vital class of targeted cancer therapies.
• Continued research is essential to overcome treatment-related toxicities and discover next-generation inhibitors.
• Future efforts will focus on improving efficacy and patient outcomes through advanced kinase inhibitor design.